Quoin Pharmaceuticals, Ltd.
QNRX
$6.97
-$0.18-2.52%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.80M | 14.04M | 18.75M | 5.41M | 7.79M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 160.20K | 303.60K | 1.26M | 602.70K | 688.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 676.00K | 987.70K | -- | -- | -- |
| Total Current Assets | 11.64M | 15.33M | 20.01M | 6.02M | 8.48M |
|
|
|||||
| Total Current Assets | 11.64M | 15.33M | 20.01M | 6.02M | 8.48M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 333.30K | 358.30K | 383.30K | 408.30K | 433.30K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 11.97M | 15.69M | 20.39M | 6.42M | 8.91M |
|
|
|||||
| Total Accounts Payable | 3.11M | 1.78M | 1.26M | 1.86M | 873.70K |
| Total Accrued Expenses | 2.90M | 2.97M | 3.68M | 3.30M | 2.86M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 600.00K | 600.00K | 600.00K | 600.00K | 600.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 6.61M | 5.35M | 5.55M | 5.76M | 4.34M |
|
|
|||||
| Total Current Liabilities | 6.61M | 5.35M | 5.55M | 5.76M | 4.34M |
| Long-Term Debt | 1.42M | 1.57M | 1.72M | 1.87M | 2.02M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 8.04M | 6.92M | 7.27M | 7.64M | 6.36M |
|
|
|||||
| Common Stock & APIC | 85.27M | 84.74M | 84.09M | 65.41M | 65.23M |
| Retained Earnings | -81.34M | -75.97M | -70.97M | -66.62M | -62.67M |
| Treasury Stock & Other | -600.00 | -200.00 | -600.00 | -- | -- |
| Total Common Equity | 3.93M | 8.77M | 13.12M | -1.21M | 2.55M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.93M | 8.77M | 13.12M | -1.21M | 2.55M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.93M | 8.77M | 13.12M | -1.21M | 2.55M |
|
|
|||||